nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—POLE4—renal system—rectum cancer	0.029	0.0502	CbGeAlD
Cladribine—POLE2—mammalian vulva—rectum cancer	0.0237	0.041	CbGeAlD
Cladribine—POLE4—female reproductive system—rectum cancer	0.0232	0.0402	CbGeAlD
Cladribine—RRM2B—seminal vesicle—rectum cancer	0.0185	0.032	CbGeAlD
Cladribine—POLE2—vagina—rectum cancer	0.0184	0.0318	CbGeAlD
Cladribine—Floxuridine—TYMS—rectum cancer	0.0175	0.557	CrCbGaD
Cladribine—POLE3—seminal vesicle—rectum cancer	0.0175	0.0302	CbGeAlD
Cladribine—PNP—renal system—rectum cancer	0.016	0.0277	CbGeAlD
Cladribine—RRM2—G1/S-Specific Transcription—TYMS—rectum cancer	0.0158	0.0404	CbGpPWpGaD
Cladribine—RRM2B—renal system—rectum cancer	0.0149	0.0258	CbGeAlD
Cladribine—RRM2B—urethra—rectum cancer	0.0146	0.0253	CbGeAlD
Cladribine—POLE3—renal system—rectum cancer	0.0141	0.0243	CbGeAlD
Cladribine—RRM1—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.0141	0.036	CbGpPWpGaD
Cladribine—RRM2B—mammalian vulva—rectum cancer	0.0139	0.0241	CbGeAlD
Cladribine—Trifluridine—TYMS—rectum cancer	0.0139	0.443	CrCbGaD
Cladribine—POLE3—urethra—rectum cancer	0.0138	0.0239	CbGeAlD
Cladribine—SLC22A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0135	0.0347	CbGpPWpGaD
Cladribine—POLE—seminal vesicle—rectum cancer	0.0133	0.023	CbGeAlD
Cladribine—POLE3—mammalian vulva—rectum cancer	0.0132	0.0228	CbGeAlD
Cladribine—PNP—female reproductive system—rectum cancer	0.0128	0.0222	CbGeAlD
Cladribine—SLC22A1—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0126	0.0323	CbGpPWpGaD
Cladribine—SLC28A3—mammalian vulva—rectum cancer	0.0123	0.0213	CbGeAlD
Cladribine—RRM2B—female reproductive system—rectum cancer	0.0119	0.0206	CbGeAlD
Cladribine—POLE2—lymph node—rectum cancer	0.0119	0.0205	CbGeAlD
Cladribine—RRM2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.0116	0.0297	CbGpPWpGaD
Cladribine—POLA1—seminal vesicle—rectum cancer	0.0115	0.0199	CbGeAlD
Cladribine—RRM2B—Nucleotide metabolism—TYMS—rectum cancer	0.0114	0.0291	CbGpPWpGaD
Cladribine—POLE3—female reproductive system—rectum cancer	0.0113	0.0195	CbGeAlD
Cladribine—RRM1—Fluoropyrimidine Activity—TYMS—rectum cancer	0.0113	0.0288	CbGpPWpGaD
Cladribine—DCK—Pyrimidine metabolism—TYMS—rectum cancer	0.0112	0.0286	CbGpPWpGaD
Cladribine—NR5A1—female reproductive system—rectum cancer	0.0109	0.0189	CbGeAlD
Cladribine—POLA1—G1/S-Specific Transcription—TYMS—rectum cancer	0.0108	0.0276	CbGpPWpGaD
Cladribine—RRM2B—vagina—rectum cancer	0.0108	0.0187	CbGeAlD
Cladribine—POLE—urethra—rectum cancer	0.0105	0.0182	CbGeAlD
Cladribine—POLE3—vagina—rectum cancer	0.0102	0.0176	CbGeAlD
Cladribine—POLE—mammalian vulva—rectum cancer	0.01	0.0174	CbGeAlD
Cladribine—PNP—Nucleotide metabolism—TYMS—rectum cancer	0.00985	0.0252	CbGpPWpGaD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00968	0.0248	CbGpPWpGaD
Cladribine—RRM2—E2F mediated regulation of DNA replication—TYMS—rectum cancer	0.00927	0.0238	CbGpPWpGaD
Cladribine—RRM2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00927	0.0238	CbGpPWpGaD
Cladribine—RRM1—seminal vesicle—rectum cancer	0.00911	0.0158	CbGeAlD
Cladribine—POLA1—urethra—rectum cancer	0.00909	0.0157	CbGeAlD
Cladribine—RRM2—renal system—rectum cancer	0.00884	0.0153	CbGeAlD
Cladribine—POLA1—mammalian vulva—rectum cancer	0.00865	0.015	CbGeAlD
Cladribine—POLE—female reproductive system—rectum cancer	0.0086	0.0149	CbGeAlD
Cladribine—POLE2—Mitotic M-M/G1 phases—RAB1A—rectum cancer	0.00846	0.0217	CbGpPWpGaD
Cladribine—RRM2—mammalian vulva—rectum cancer	0.00827	0.0143	CbGeAlD
Cladribine—POLE—vagina—rectum cancer	0.00778	0.0135	CbGeAlD
Cladribine—RRM1—smooth muscle tissue—rectum cancer	0.00763	0.0132	CbGeAlD
Cladribine—RRM1—renal system—rectum cancer	0.00734	0.0127	CbGeAlD
Cladribine—RRM1—urethra—rectum cancer	0.00722	0.0125	CbGeAlD
Cladribine—RRM2—female reproductive system—rectum cancer	0.00708	0.0122	CbGeAlD
Cladribine—DCK—seminal vesicle—rectum cancer	0.00708	0.0122	CbGeAlD
Cladribine—RRM2B—lymph node—rectum cancer	0.00697	0.0121	CbGeAlD
Cladribine—SLC22A2—renal system—rectum cancer	0.00689	0.0119	CbGeAlD
Cladribine—RRM1—mammalian vulva—rectum cancer	0.00687	0.0119	CbGeAlD
Cladribine—POLA1—vagina—rectum cancer	0.0067	0.0116	CbGeAlD
Cladribine—POLE3—lymph node—rectum cancer	0.00659	0.0114	CbGeAlD
Cladribine—POLE2—DNA Repair—SMUG1—rectum cancer	0.00645	0.0165	CbGpPWpGaD
Cladribine—RRM2—vagina—rectum cancer	0.0064	0.0111	CbGeAlD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00636	0.0163	CbGpPWpGaD
Cladribine—POLA1—E2F mediated regulation of DNA replication—TYMS—rectum cancer	0.00634	0.0162	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00633	0.0162	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—TYMS—rectum cancer	0.00597	0.0153	CbGpPWpGaD
Cladribine—RRM1—female reproductive system—rectum cancer	0.00588	0.0102	CbGeAlD
Cladribine—RRM1—Nucleotide metabolism—TYMS—rectum cancer	0.00566	0.0145	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—RAB1A—rectum cancer	0.00566	0.0145	CbGpPWpGaD
Cladribine—DCK—urethra—rectum cancer	0.0056	0.00969	CbGeAlD
Cladribine—POLE—Mitotic M-M/G1 phases—RAB1A—rectum cancer	0.00545	0.014	CbGpPWpGaD
Cladribine—DCK—mammalian vulva—rectum cancer	0.00534	0.00923	CbGeAlD
Cladribine—RRM1—vagina—rectum cancer	0.00532	0.0092	CbGeAlD
Cladribine—POLE2—G1/S Transition—TYMS—rectum cancer	0.00531	0.0136	CbGpPWpGaD
Cladribine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.00529	0.0136	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00519	0.0133	CbGpPWpGaD
Cladribine—POLE—lymph node—rectum cancer	0.00503	0.0087	CbGeAlD
Cladribine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.00493	0.0126	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00492	0.0126	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—TYMS—rectum cancer	0.00491	0.0126	CbGpPWpGaD
Cladribine—SLC22A1—renal system—rectum cancer	0.00487	0.00842	CbGeAlD
Cladribine—RRM2—Nucleotide metabolism—TYMS—rectum cancer	0.00466	0.0119	CbGpPWpGaD
Cladribine—DCK—female reproductive system—rectum cancer	0.00457	0.0079	CbGeAlD
Cladribine—POLE2—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00448	0.0115	CbGpPWpGaD
Cladribine—DCK—Nucleotide metabolism—TYMS—rectum cancer	0.00436	0.0112	CbGpPWpGaD
Cladribine—POLA1—lymph node—rectum cancer	0.00434	0.0075	CbGeAlD
Cladribine—ABCG2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00433	0.0111	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00427	0.0109	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00425	0.0109	CbGpPWpGaD
Cladribine—RRM2B—DNA Damage Response—TP53—rectum cancer	0.00421	0.0108	CbGpPWpGaD
Cladribine—POLE—DNA Repair—SMUG1—rectum cancer	0.00415	0.0106	CbGpPWpGaD
Cladribine—RRM2—lymph node—rectum cancer	0.00414	0.00716	CbGeAlD
Cladribine—DCK—vagina—rectum cancer	0.00413	0.00715	CbGeAlD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.0041	0.0105	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00408	0.0104	CbGpPWpGaD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—TP53—rectum cancer	0.00406	0.0104	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00399	0.0102	CbGpPWpGaD
Cladribine—ABCG2—seminal vesicle—rectum cancer	0.00395	0.00683	CbGeAlD
Cladribine—POLA1—Mitotic M-M/G1 phases—RAB1A—rectum cancer	0.00388	0.00995	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—RAB1A—rectum cancer	0.0038	0.00972	CbGpPWpGaD
Cladribine—RRM1—Fluoropyrimidine Activity—TP53—rectum cancer	0.00374	0.00957	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—RAB1A—rectum cancer	0.00364	0.00933	CbGpPWpGaD
Cladribine—RRM2—G1/S Transition—TYMS—rectum cancer	0.00357	0.00913	CbGpPWpGaD
Cladribine—SLC22A1—vagina—rectum cancer	0.00352	0.0061	CbGeAlD
Cladribine—ABCG2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00347	0.00888	CbGpPWpGaD
Cladribine—RRM1—lymph node—rectum cancer	0.00344	0.00595	CbGeAlD
Cladribine—POLE—G1/S Transition—TYMS—rectum cancer	0.00342	0.00877	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—TYMS—rectum cancer	0.00336	0.00861	CbGpPWpGaD
Cladribine—ABCG2—urethra—rectum cancer	0.00313	0.00541	CbGeAlD
Cladribine—RRM2—Fluoropyrimidine Activity—TP53—rectum cancer	0.00308	0.00788	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.003	0.0077	CbGpPWpGaD
Cladribine—ABCG2—mammalian vulva—rectum cancer	0.00298	0.00515	CbGeAlD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00292	0.00748	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.0029	0.00744	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00288	0.00739	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00276	0.00708	CbGpPWpGaD
Cladribine—DCK—lymph node—rectum cancer	0.00267	0.00462	CbGeAlD
Cladribine—POLA1—Cell Cycle—RAB1A—rectum cancer	0.0026	0.00665	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—ITGA2—rectum cancer	0.00258	0.00661	CbGpPWpGaD
Cladribine—POLE2—G1 to S cell cycle control—TP53—rectum cancer	0.00257	0.00658	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—TYMS—rectum cancer	0.00244	0.00625	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.0024	0.00616	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—TP53—rectum cancer	0.00236	0.00605	CbGpPWpGaD
Cladribine—ABCG2—vagina—rectum cancer	0.00231	0.00399	CbGeAlD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00224	0.00574	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00211	0.0054	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00206	0.00526	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00172	0.00441	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—TP53—rectum cancer	0.00166	0.00424	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—TYMS—rectum cancer	0.00164	0.0042	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00156	0.00399	CbGpPWpGaD
Cladribine—ABCG2—lymph node—rectum cancer	0.00149	0.00258	CbGeAlD
Cladribine—POLE2—Cell Cycle—TYMS—rectum cancer	0.00147	0.00376	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00142	0.00363	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00136	0.00348	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00132	0.00339	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00123	0.00316	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00122	0.00313	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—rectum cancer	0.00115	0.00295	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00114	0.00292	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—TYMS—rectum cancer	0.0011	0.00282	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—TYMS—rectum cancer	0.00106	0.00271	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—TYMS—rectum cancer	0.00103	0.00264	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.00103	0.00264	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TYMS—rectum cancer	0.000985	0.00252	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.000969	0.00248	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TYMS—rectum cancer	0.000946	0.00242	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000917	0.00235	CbGpPWpGaD
Cladribine—PNP—Metabolism—TYMS—rectum cancer	0.000895	0.00229	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—TYMS—rectum cancer	0.000754	0.00193	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—NRAS—rectum cancer	0.000725	0.00186	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TYMS—rectum cancer	0.000674	0.00173	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—KRAS—rectum cancer	0.000624	0.0016	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000581	0.00149	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—HRAS—rectum cancer	0.000531	0.00136	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000516	0.00132	CbGpPWpGaD
Cladribine—RRM1—Metabolism—TYMS—rectum cancer	0.000514	0.00132	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—rectum cancer	0.000487	0.00125	CbGpPWpGaD
Cladribine—RRM2—Metabolism—TYMS—rectum cancer	0.000423	0.00108	CbGpPWpGaD
Cladribine—DCK—Metabolism—TYMS—rectum cancer	0.000396	0.00101	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—rectum cancer	0.000327	0.000837	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—rectum cancer	0.000314	0.000804	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000258	0.00066	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—HRAS—rectum cancer	0.00024	0.000615	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—rectum cancer	0.000224	0.000573	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—HRAS—rectum cancer	0.000197	0.000505	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—HRAS—rectum cancer	0.000184	0.000471	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TYMS—rectum cancer	0.000158	0.000406	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TYMS—rectum cancer	0.000157	0.000401	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TYMS—rectum cancer	0.000146	0.000374	CbGpPWpGaD
